홈 › 대장직장암 › 텍사스

텍사스의 대장직장암 임상 시험

대장직장암 관련 연구 145개가 텍사스 내 여러 지역에서 참여자를 모집하고 있습니다.

텍사스의 도시

공식 연구 텍스트(영어)

A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer

NEXT Houston, Houston

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07693751

Initial Safety of SFM Plus OTOLoc for Creating Side-to-side or End-to-side Colorectal Anastomoses

University of Texas Health Science Center, Houston

피험자 모집 중

22세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07276529

Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer

The University of Texas M. D. Anderson Cancer Center, Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06959550

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

M D Anderson Cancer Center, Houston

피험자 모집 중

18세 이상 · 여성 · 2026. 11. 12. 업데이트됨 · NCT05649072

Precision-MRD: Prospective Observational Study of Biomarker-directed Systemic Therapy for Colorectal Cancer Patients With Minimal Residual Disease

MD Anderson Cancer Center, Houston

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06878131

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

START Dallas Fort Worth, Fort Worth
The University of Texas MD Anderson Cancer Center, Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07659795

Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer

MD Anderson Cancer Center, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07500298

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

NEXT Austin, Austin
START Center for Clinical Research, Fort Worth
University of Texas MD Anderson Cancer Center, Houston
외 2개

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06270706

A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

The University of Texas MD Anderson Cancer Center, Houston
NEXT Oncology, San Antonio

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07458347

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

MD Anderson Cancer Center, Houston
START San Antonio, San Antonio

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06004245

Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study

M D Anderson Cancer Center, Houston

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT04739072

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

MD Anderson Cancer Center, Houston

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT07020221

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston
The University of Texas, MD Anderson Cancer Center - West Houston, Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT04557449

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

NEXT Texas LLC - Austin, Austin
START Dallas Fort Worth, LLC, Fort Worth
MD Anderson, Houston
외 4개

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT07503808

Role of Diet on the Microbiome of the Digestive System

M D Anderson Cancer Center, Houston

피험자 모집 중관찰 연구

45세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT04666727

Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

UT MD Anderson Cancer Center, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT06102902

A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

Texas Oncology - Northeast Texas, Denton
Texas Oncology - Gulf Coast, Webster

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT04929223

A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston
University of Texas at Tyler, Tyler

피험자 모집 중1상

18세 ~ 99세 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT06983743

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

The Methodist Hospital Research Institute, Houston
The University of Texas MD Anderson Cancer Center, Houston

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06324357

A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome

MD Anderson Cancer Center, Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT05411718

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

The University of Texas MD Anderson Cancer Center - Conroe, Conroe
The University of Texas - M.D. Anderson Cancer Center, Houston
The University of Texas, MD Anderson Cancer Center - West Houston, Houston
외 3개

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07318805

Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer

Community Clinical Trials, Kingwood

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06824064

A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

Texas Oncology, P.A. - Abilene - 300210366, Abilene
Texas Oncology-South Austin, Austin
Texas Oncology DFW, Bedford
외 2개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07549412

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Clinical Study Site, Dallas
Clinical Study Site, Dallas
Clinical Study Site, Fort Worth
외 3개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07228832

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

The Don and Sybil Harrington Cancer Center, Amarillo
UT MD Anderson Cancer Center, Houston
Audie L Murphy VA Hospital, San Antonio

피험자 모집 중관찰 연구건강한 지원자 환영

40세 ~ 75세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05334069

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

The University of Texas - MD Anderson Cancer Center, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06400472

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Texas Oncology - DFW (Sammons CC), Dallas
Baylor College of Medicine, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07213791

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Texas Oncology - DFW (Sammons CC), Dallas
MD Anderson Cancer Center, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07114601

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06760819

Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

MD Anderson Cancer Center, Houston
NEXT Dallas, Irving
NEXT Oncology, San Antonio

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07397338

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

Texas Oncology - DFW, Dallas
MD Anderson Cancer Center, Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06695845

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

Texas Oncology West Texas, Abilene
Texas Oncology DFW, Dallas
UT Southwestern, Dallas
외 4개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT06662786

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

Texas Oncology West Texas, Abilene
Parkland Health and Hospital System, Dallas
Texas Oncology DFW, Dallas
외 6개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT06750094

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

University of Texas Southwestern Medical Center, Dallas

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT05856981

A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

NEXT Oncology Austin, Austin
START Dallas Fort Worth, Dallas
START San Antonio, San Antonio

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07542704

A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer

MD Anderson Cancer Center, Houston

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT05379595

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

MD Anderson Cancer Center, Houston
NEXT Dallas, Irving

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07578571

A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

NEXT Oncology, San Antonio

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT06720987

A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)

MD Anderson Cancer Center, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07416552

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Texas Oncology, Dallas
Oncology Consultants, Houston
Texas Oncology, Tyler

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT03526835

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.